¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : ±Ô¸ð ºÐ¼®, ±â¼úº°, Àü´Þ °æ·Îº°, »ý»ê ±â¼úº°, Àç·áº°, Áö¿ªº°, ¿¹Ãø(2022-2032³â)
Global Ophthalmic Drug Delivery Systems Market Size Study, By Technology, By Delivery Route, By Production Technology, By Material, and Regional Forecasts 2022-2032
»óǰÄÚµå : 1637973
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ ¾à 147¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ CAGRÀº 6.6%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ¼ºÀåÀº ¹é³»Àå, ³ì³»Àå, ³ëÈ­ Ȳ¹Ý º¯¼ºÁõ µî ´« ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¼¼°è 22¾ï ¸í ÀÌ»óÀÌ ½Ã°¢ °ü·Ã ¹®Á¦¿¡ ½Ã´Þ¸®°í ÀÖÀ¸¸ç, ´ëºÎºÐÀº Çõ½ÅÀûÀÎ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ÀÇÇÑ °íµµÀÇ Ä¡·á°¡ ÇÊ¿äÇÏ´Ù°í ÇÕ´Ï´Ù.

ÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ¼­¹æÇü ÀÓÇöõÆ®, ÇÏÀ̵å·Î°Ö, ³ª³ëÀÔÀÚ¸¦ º£À̽º·Î ÇÑ µô¸®¹ö¸® ½Ã½ºÅÛÀ̶ó°í ÇÏ´Â ¼±Áø ±â¼úÀÇ Ã¤¿ëÀ̸ç, À̰Ϳ¡ ÀÇÇØ ¾à¹°ÀÇ »ýüÀÌ¿ë·ü°ú Ä¡·á ¼ºÀûÀÌ Çâ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â ³·Àº ü·ù¼º ¹× Èí¼ö Á¦ÇѰú °°Àº ÀüÅëÀûÀÎ Á¡¾ÈÁ¦ÀÇ ÇѰ踦 ÇØ°áÇϰí Ç¥ÀûÈ­µÈ ¾à¹° ¼­¹æ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±æÀ» ¿­¾îÁÝ´Ï´Ù. ¶ÇÇÑ Ä¡·á¾÷°è¿¡¼­´Â ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ Áß½ÃÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖÀ¸¸ç, ³·Àº ħ½À ¹× Àå½Ã°£ ÀÛ¿ëÇüÀÇ ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ °³¹ßÀÌ ÃËÁøµÇ¾î Ä¡·á È¿À²ÀÌ ´ëÆø Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

°Ô´Ù°¡ Çõ½ÅÀûÀÎ Á¦Ç°¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú Á¦¾à ´ë±â¾÷ÀÇ ¿¬±¸ °³¹ß¿¡ ¸¹Àº ÅõÀÚ°¡ ÀÌ ºÐ¾ßÀÇ °­·ÂÇÑ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÇÏÀ̵å·Î°Ö°ú Æú¸®Ä«ÇÁ·Î¶ôÅæ°ú °°Àº »ýüÀûÇÕ¼º Àç·á´Â ¾à¹°Àü´Þ ¼º´É°ú ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â ´É·ÂÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ ¹°ÁúÀº Áö¼ÓÀûÀÎ ¾à¹° ¹æÃâ ¸ÞÄ¿´ÏÁòÀ» º¸ÀåÇÏ°í ºó¹øÇÑ Àû¿ëÀÇ Çʿ伺À» ÁÙÀ̰í ȯÀÚÀÇ ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù.

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì°¡ ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, ±× ¹è°æ¿¡´Â È®¸³µÈ ÇコÄɾî ÀÎÇÁ¶ó, ¾öû³­ ¿¬±¸°³¹ß ÅõÀÚ, ´« °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸ °í·ÉÈ­, ÀÇ·á ½Ã¼³ Á¢±Ù¼º Çâ»ó, Çõ½ÅÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÇ Á߿伺 Áõ°¡¿¡ ÈûÀÔ¾î ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀÇ »ó¼¼ÇÑ ºÎ¹®¿Í ÇÏÀ§ ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°è ¾È°ú ¾à¹° Àü´Þ ½Ã½ºÅÛ ½ÃÀå : Á¤ÀÇ¿Í ºÐ¼®ÀÇ ÀüÁ¦

Á¦3Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±â¼úº°(2022-2032³â)

Á¦6Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü´Þ °æ·Îº°(2022-2032³â)

Á¦7Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : »ý»ê±â¼úº°(2022-2032³â)

Á¦8Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àç·áº°(2022-2032³â)

Á¦9Àå ¼¼°èÀÇ ¾È°ú ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022-2032³â)

Á¦10Àå °æÀï Á¤º¸

Á¦11Àå ºÐ¼® ÇÁ·Î¼¼½º

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global ophthalmic drug delivery systems market is valued at approximately USD 14.78 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2032. This growth is propelled by an increasing prevalence of eye disorders such as cataracts, glaucoma, and age-related macular degeneration. According to the World Health Organization, over 2.2 billion people globally are affected by vision-related problems, with many cases requiring advanced treatments facilitated by innovative drug delivery systems.

The market is driven by the adoption of advanced technologies like sustained-release implants, hydrogels, and nanoparticle-based delivery systems, which improve drug bioavailability and therapeutic outcomes. These advancements address limitations of traditional eye drops, such as poor retention and limited absorption, paving the way for targeted and sustained drug release solutions. The industry has also seen a growing focus on patient compliance, which has encouraged the development of minimally invasive and long-acting drug delivery systems, significantly enhancing treatment efficiency.

Furthermore, regulatory support for innovative products and heavy investments in R&D by pharmaceutical giants contribute to the sector's robust growth. Biocompatible materials like hydrogels and polycaprolactone are gaining prominence due to their ability to improve drug delivery performance and patient safety. These materials ensure sustained-release drug mechanisms, reducing the need for frequent applications and enhancing patient convenience.

Geographically, North America leads the market, driven by a well-established healthcare infrastructure, significant R&D investments, and rising awareness of eye health. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth, fueled by an aging population, increased access to healthcare facilities, and a growing emphasis on innovative treatment solutions.

Major Market Players Included in This Report Are:

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Technology:

By Delivery Route:

By Production Technology:

By Material:

By Region:

North America:

Europe:

Asia-Pacific:

Latin America:

Middle East & Africa:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Ophthalmic Drug Delivery Systems Market Executive Summary

Chapter 2. Global Ophthalmic Drug Delivery Systems Market Definition and Research Assumptions

Chapter 3. Global Ophthalmic Drug Delivery Systems Market Dynamics

Chapter 4. Global Ophthalmic Drug Delivery Systems Market Industry Analysis

Chapter 5. Global Ophthalmic Drug Delivery Systems Market Size & Forecasts by Technology (2022-2032)

Chapter 6. Global Ophthalmic Drug Delivery Systems Market Size & Forecasts by Delivery Route (2022-2032)

Chapter 7. Global Ophthalmic Drug Delivery Systems Market Size & Forecasts by Production Technology (2022-2032)

Chapter 8. Global Ophthalmic Drug Delivery Systems Market Size & Forecasts by Material (2022-2032)

Chapter 9. Global Ophthalmic Drug Delivery Systems Market Size & Forecasts by Region (2022-2032)

Chapter 10. Competitive Intelligence

Chapter 11. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â